Imaging advocates, including the American College of Cardiology, cautioned against giving too much credence to a study in the New England Journal of Medicine concluding that adults are exposed to excessive doses of radiation from medical imaging procedures that are not supported by the clinical data.
Imaging advocates, including the American College of Cardiology, cautioned against giving too much credence to a study in the New England Journal of Medicine concluding that adults are exposed to excessive doses of radiation from medical imaging procedures that are not supported by the clinical data.
"It is important to understand this to provide context and avoid unnecessary hysteria that may lead to patients foregoing necessary imaging care and placing their health in jeopardy," the ACR said.
For most patients, repeated exams and high levels of radiation are not a reality.
The journal's retrospective cohort study covered more than 655,000 patients younger than 65 and found a majority underwent at least one imaging procedure, some of them at doses exceeding 50 mSv per year. An editorial accompanying the study took particular aim at cardiac and myocardial perfusion imaging.
No large-scale, randomized trials have shown imaging for patients with heart disease prolongs life, improves quality of life, prevents major clinical events, or reduces long-term medical costs, said Dr. Michael S. Lauer, director of the division of prevention and population science at the National Heart, Lung, and Blood Institute, which is a part of the National Institutes of Health (NEJM 2009;361:841-843). Overall, moderate effective doses (between 3 mSv and 20 mSv per year) were incurred at an annual rate of 193.8 per 1000 patients. High (between 20 mSv and 50 mSv per year), and very high (greater than 50 mSv per year) effective doses were incurred at an annual rate of 18.6 and 1.9 per 1000 patients.
CT of the abdomen, pelvis, and chest accounted for nearly 38% of the total effective dose in the study. Myocardial perfusion imaging accounted for 22%.
The patients who experienced the higher doses of radiation were almost certainly cancer patients and others with chronic illnesses whose conditions necessitated repeat exams to gauge effectiveness of their treatment, according to the ACR. For most patients, repeated exams and high levels of radiation are not a reality, the ACR said.
Linking medical imaging to cancer risk is not a proven fact, according to Dr. Joseph Schoepf, a professor of radiology and cardiology at the Medical University of South Carolina in Charleston.
"All estimates of cancer risk from radiation are extrapolations of data collected in WWII atomic bomb survivors," he said. "It is highly questionable whether these data can be applied to patients receiving the kind and level of radiation involved with medical imaging."
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.